Word

CBC COMPREHENSIVE BIOMARKER CENTER

Status

Dead

Status Code

404

Status Date

Saturday, April 16, 2022

Serial Number

79118333

Registration Number

4486693

Registration Date

Tuesday, February 25, 2014

Mark Type

3000

Filing Date

Monday, April 16, 2012

Published for Opposition

Tuesday, December 10, 2013

Cancellation Date

Saturday, April 16, 2022

Trademark Owner History

Comprehensive Biomarker Center GmbH - Original Registrant
febit holding GmbH - Owner At Publication

Classifications

35 professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector featuring chemical and biochemical reagents for genetic analysis and testing; market reports and studies

44 Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical and veterinary diagnostic services in preclinical and clinical settings; medical and clinical examinations

42 scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the field of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely, analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkers

The mark consists of the letters "cbc" at the top of the mark with the first "c" being black, the "b", from left to right, being mostly black with two diagonal white stripes and then the remainder light green, the second "c" is light green turning green at the bottom; six green dots are in a vertical stack below the first "c" and to their right in black is the wording "Comprehensive Biomarker Center".
The color(s) black, white, green and light green is/are claimed as a feature of the mark.
"COMPREHENSIVE BIOMARKER CENTER"

Trademark Events

Nov 13, 2022

Notification Of Effect Of Cancellation Of Intl Reg Mailed

Nov 13, 2022

Death Of International Registration

Feb 5, 2022

Total Invalidation Processed By The Ib

Jan 11, 2022

Total Invalidation Of Reg Ext Protection Sent To Ib

Jan 11, 2022

Invalidation Processed

Oct 26, 2021

Total Invalidation Of Reg Ext Protection Created

Feb 26, 2021

Cancelled Section 71

Jun 9, 2016

New Representative At Ib Received

Oct 28, 2014

Correction From The Ib Examined, No Action Is Needed

Oct 23, 2014

Correction Transaction Received From Ib

Jun 27, 2014

Final Decision Transaction Processed By Ib

Jun 11, 2014

Final Disposition Notice Sent To Ib

Jun 10, 2014

Final Disposition Processed

May 25, 2014

Final Disposition Notice Created, To Be Sent To Ib

May 6, 2014

Correction From Ib Entered - No Review Required

Apr 24, 2014

Correction Transaction Received From Ib

Feb 25, 2014

Registered-Principal Register

Feb 2, 2014

Notification Processed By Ib

Dec 23, 2013

Change Of Owner Received From Ib

Dec 10, 2013

Published For Opposition

Nov 20, 2013

Notification Of Possible Opposition Sent To Ib

Nov 20, 2013

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Nov 20, 2013

Notice Of Publication

Nov 4, 2013

Law Office Publication Review Completed

Oct 25, 2013

Assigned To Lie

Oct 10, 2013

Approved For Pub - Principal Register

Sep 21, 2013

Teas/Email Correspondence Entered

Sep 20, 2013

Correspondence Received In Law Office

Sep 20, 2013

Teas Response To Office Action Received

Mar 26, 2013

Non-Final Action Mailed

Mar 26, 2013

Non-Final Action Written

Mar 4, 2013

Teas/Email Correspondence Entered

Mar 4, 2013

Correspondence Received In Law Office

Mar 4, 2013

Teas Response To Office Action Received

Nov 15, 2012

Refusal Processed By Ib

Oct 22, 2012

Non-Final Action Mailed - Refusal Sent To Ib

Oct 22, 2012

Refusal Processed By Mpu

Oct 20, 2012

Non-Final Action (Ib Refusal) Prepared For Review

Oct 19, 2012

Non-Final Action Written

Oct 19, 2012

Application Filing Receipt Mailed

Oct 15, 2012

Assigned To Examiner

Oct 15, 2012

New Application Office Supplied Data Entered In Tram

Oct 11, 2012

Sn Assigned For Sect 66a Appl From Ib